S&P 500   4,595.48 (+0.64%)
DOW   35,878.36 (+0.38%)
QQQ   381.63 (+0.98%)
AAPL   149.61 (+0.65%)
MSFT   310.61 (+0.80%)
FB   320.92 (-2.36%)
GOOGL   2,778.04 (+1.06%)
TSLA   1,058.76 (+3.31%)
AMZN   3,404.75 (+2.54%)
NVDA   249.30 (+7.61%)
BABA   171.58 (-2.61%)
NIO   41.51 (+0.58%)
CGC   13.45 (-0.88%)
GE   108.75 (+3.28%)
AMD   125.36 (+2.45%)
MU   69.06 (+0.44%)
T   25.52 (-0.47%)
F   15.92 (-0.50%)
ACB   7.08 (-1.39%)
DIS   172.74 (+0.42%)
PFE   43.27 (+0.28%)
BA   213.22 (+0.16%)
AMC   36.19 (-1.74%)
S&P 500   4,595.48 (+0.64%)
DOW   35,878.36 (+0.38%)
QQQ   381.63 (+0.98%)
AAPL   149.61 (+0.65%)
MSFT   310.61 (+0.80%)
FB   320.92 (-2.36%)
GOOGL   2,778.04 (+1.06%)
TSLA   1,058.76 (+3.31%)
AMZN   3,404.75 (+2.54%)
NVDA   249.30 (+7.61%)
BABA   171.58 (-2.61%)
NIO   41.51 (+0.58%)
CGC   13.45 (-0.88%)
GE   108.75 (+3.28%)
AMD   125.36 (+2.45%)
MU   69.06 (+0.44%)
T   25.52 (-0.47%)
F   15.92 (-0.50%)
ACB   7.08 (-1.39%)
DIS   172.74 (+0.42%)
PFE   43.27 (+0.28%)
BA   213.22 (+0.16%)
AMC   36.19 (-1.74%)
S&P 500   4,595.48 (+0.64%)
DOW   35,878.36 (+0.38%)
QQQ   381.63 (+0.98%)
AAPL   149.61 (+0.65%)
MSFT   310.61 (+0.80%)
FB   320.92 (-2.36%)
GOOGL   2,778.04 (+1.06%)
TSLA   1,058.76 (+3.31%)
AMZN   3,404.75 (+2.54%)
NVDA   249.30 (+7.61%)
BABA   171.58 (-2.61%)
NIO   41.51 (+0.58%)
CGC   13.45 (-0.88%)
GE   108.75 (+3.28%)
AMD   125.36 (+2.45%)
MU   69.06 (+0.44%)
T   25.52 (-0.47%)
F   15.92 (-0.50%)
ACB   7.08 (-1.39%)
DIS   172.74 (+0.42%)
PFE   43.27 (+0.28%)
BA   213.22 (+0.16%)
AMC   36.19 (-1.74%)
S&P 500   4,595.48 (+0.64%)
DOW   35,878.36 (+0.38%)
QQQ   381.63 (+0.98%)
AAPL   149.61 (+0.65%)
MSFT   310.61 (+0.80%)
FB   320.92 (-2.36%)
GOOGL   2,778.04 (+1.06%)
TSLA   1,058.76 (+3.31%)
AMZN   3,404.75 (+2.54%)
NVDA   249.30 (+7.61%)
BABA   171.58 (-2.61%)
NIO   41.51 (+0.58%)
CGC   13.45 (-0.88%)
GE   108.75 (+3.28%)
AMD   125.36 (+2.45%)
MU   69.06 (+0.44%)
T   25.52 (-0.47%)
F   15.92 (-0.50%)
ACB   7.08 (-1.39%)
DIS   172.74 (+0.42%)
PFE   43.27 (+0.28%)
BA   213.22 (+0.16%)
AMC   36.19 (-1.74%)
NYSE:HEXO

HEXO Stock Forecast, Price & News

$1.68
-0.03 (-1.47 %)
(As of 10/26/2021 11:02 AM ET)
Add
Compare
Today's Range
$1.66
$1.72
50-Day Range
$1.69
$3.95
52-Week Range
$1.67
$11.04
Volume97,043 shs
Average Volume7.42 million shs
Market Capitalization$255.82 million
P/E RatioN/A
Dividend YieldN/A
Beta1.13
30 days | 90 days | 365 days | Advanced Chart
Receive HEXO News and Ratings via Email

Sign-up to receive the latest news and ratings for HEXO and its competitors with MarketBeat's FREE daily newsletter.


HEXO logo

About HEXO

HEXO Corp. is a consumer packaged goods cannabis company, which creates and distributes products to serve the global cannabis market. It serves the Canadian adult-use markets under its HEXO Cannabis, Up Cannabis and Original Stash brands, and the medical market under HEXO medical cannabis. The company was founded by Sébastien St. Louis and Adam Miron on October 29, 2013 and is headquartered in Kanata, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Medicinals & botanicals
Sub-Industry
N/A
Sector
Medical
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
$60.46 million
Book Value
$3.43 per share

Profitability

Net Income
$-406.37 million
Net Margins
-189.28%

Debt

Price-To-Earnings

Miscellaneous

Market Cap
$255.82 million
Next Earnings Date
11/4/2021 (Estimated)
Optionable
Optionable

MarketRank

Overall MarketRank

1.64 out of 5 stars

Medical Sector

956th out of 1,360 stocks

Medicinals & Botanicals Industry

8th out of 19 stocks

Analyst Opinion: 3.1Community Rank: 3.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -












HEXO (NYSE:HEXO) Frequently Asked Questions

Is HEXO a buy right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for HEXO in the last twelve months. There are currently 2 sell ratings, 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" HEXO stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HEXO, but not buy additional shares or sell existing shares.
View analyst ratings for HEXO
or view top-rated stocks.

What stocks does MarketBeat like better than HEXO?

Wall Street analysts have given HEXO a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but HEXO wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is HEXO's next earnings date?

HEXO is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for HEXO
.

How were HEXO's earnings last quarter?

HEXO Corp. (NYSE:HEXO) released its earnings results on Sunday, June, 13th. The company reported ($0.17) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.06) by $0.11. The business had revenue of $17.95 million for the quarter, compared to analyst estimates of $27.96 million. HEXO had a negative net margin of 189.28% and a negative trailing twelve-month return on equity of 12.50%.
View HEXO's earnings history
.

How has HEXO's stock price been impacted by Coronavirus?

HEXO's stock was trading at $0.9376 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, HEXO shares have increased by 81.3% and is now trading at $1.70.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for HEXO?

7 brokerages have issued 1 year price targets for HEXO's stock. Their forecasts range from $3.40 to $10.00. On average, they expect HEXO's stock price to reach $6.69 in the next twelve months. This suggests a possible upside of 293.6% from the stock's current price.
View analysts' price targets for HEXO
or view top-rated stocks among Wall Street analysts.

Who are HEXO's key executives?

HEXO's management team includes the following people:
  • Michael Munzar, Chairman & Medical Director
  • Sébastien St. Louis, President, Chief Executive Officer & Director
  • Donald J. Courtney, Chief Operating Officer
  • Trent MacDonald, Chief Financial Officer
  • Charles Bowman, General Manager-US Operations

What is Sebastien St. Louis' approval rating as HEXO's CEO?

11 employees have rated HEXO CEO Sebastien St. Louis on Glassdoor.com. Sebastien St. Louis has an approval rating of 63% among HEXO's employees. This puts Sebastien St. Louis in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of HEXO own?

Based on aggregate information from My MarketBeat watchlists, some companies that other HEXO investors own include (APHA), (CGC), Cronos Group (CRON), The Walt Disney (DIS), GlaxoSmithKline (GSK), Summit Hotel Properties (INN), Kensington Capital Acquisition Corp. II (KCAC), Kosmos Energy (KOS), Micron Technology (MU) and NIO (NIO).

What is HEXO's stock symbol?

HEXO trades on the New York Stock Exchange (NYSE) under the ticker symbol "HEXO."

Who are HEXO's major shareholders?

HEXO's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Clear Street Markets LLC (0.03%).

Which major investors are buying HEXO stock?

HEXO stock was purchased by a variety of institutional investors in the last quarter, including Clear Street Markets LLC.

How do I buy shares of HEXO?

Shares of HEXO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is HEXO's stock price today?

One share of HEXO stock can currently be purchased for approximately $1.70.

How much money does HEXO make?

HEXO has a market capitalization of $259.64 million and generates $60.46 million in revenue each year. The company earns $-406.37 million in net income (profit) each year or ($0.96) on an earnings per share basis.

What is HEXO's official website?

The official website for HEXO is www.hexocorp.com.

How can I contact HEXO?

The company can be reached via phone at (866) 438-8429 or via email at [email protected].


This page was last updated on 10/26/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.